Found 39 matching trials
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease PHASE1 CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B cell mediated...
Show More Location
Children's Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma PHASE1 This phase I trial studies the side effects and best dose of BCMA CART cell...
Show More Location
Shenzhen Second People's Hospital,The first affiliated hospital of Shenzhen University
Learn More & Join Trial
Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease PHASE2 The goal of this clinical trial is to test the safety and potential benefit...
Show More Location
Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital
Learn More & Join Trial
A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C)in Patients With Refractory Primary Immune Thrombocytopenia EARLY_PHASE1 This is an investigator-initiated trial to evaluate the safety and efficacy...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R MM PHASE1 The goal of this clinical trial is to study the feasibility and efficacy of...
Show More Location
Department of Hematology ,Fudan University Zhongshan Hospital
Learn More & Join Trial
UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia Gravis EARLY_PHASE1 This is an open label, single-site, dose-escalation study in up to 18 parti...
Show More Location
The first affiliated hospital of medical college of zhejiang university
Learn More & Join Trial
CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed โฅ3 Lines of Therapy. PHASE1 This is an investigator-initiated trial to evaluate the safety and efficacy...
Show More Location
Regenerative Medicine Center and Red Blood Cell Disorders Center
Learn More & Join Trial
Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy N/A The goal of this observational study is to learn about vaccine immunity in ...
Show More Location
University Hospital Bern
Learn More & Join Trial
BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy PHASE1 This single-arm, open-label, phase I trial evaluates the safety and tolerab...
Show More Location
West China Hospital, Sichuan University
Learn More & Join Trial
SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus PHASE1 study evaluates a biomarker-guided strategy to assign adults with refractor...
Show More Location
Peking University Shenzhen Hospital
Learn More & Join Trial